These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 29497966)

  • 1. Coating and Pharmacokinetic Evaluation of Air Spray Coated Drug Coated Balloons.
    Turner EA; Atigh MK; Erwin MM; Christians U; Yazdani SK
    Cardiovasc Eng Technol; 2018 Jun; 9(2):240-250. PubMed ID: 29497966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro particulate and in vivo drug retention study of a novel polyethylene oxide formulation for drug-coated balloons.
    Anderson JA; Lamichhane S; Vierhout T; Sherman A; Engebretson D; Pohlson K; Remund T; Kelly P
    J Vasc Surg; 2018 May; 67(5):1537-1545.e7. PubMed ID: 28843789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of paclitaxel coatings for delivery via drug-coated balloons.
    Kempin W; Kaule S; Reske T; Grabow N; Petersen S; Nagel S; Schmitz KP; Weitschies W; Seidlitz A
    Eur J Pharm Biopharm; 2015 Oct; 96():322-8. PubMed ID: 26318979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes From the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies.
    Krishnan P; Faries P; Niazi K; Jain A; Sachar R; Bachinsky WB; Cardenas J; Werner M; Brodmann M; Mustapha JA; Mena-Hurtado C; Jaff MR; Holden AH; Lyden SP
    Circulation; 2017 Sep; 136(12):1102-1113. PubMed ID: 28729250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients.
    Radke PW; Joner M; Joost A; Byrne RA; Hartwig S; Bayer G; Steigerwald K; Wittchow E
    EuroIntervention; 2011 Oct; 7(6):730-7. PubMed ID: 21986331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular, downstream, and pharmacokinetic responses to treatment with a low dose drug-coated balloon in a swine femoral artery model.
    Yazdani SK; Pacheco E; Nakano M; Otsuka F; Naisbitt S; Kolodgie FD; Ladich E; Rousselle S; Virmani R
    Catheter Cardiovasc Interv; 2014 Jan; 83(1):132-40. PubMed ID: 23703778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-Clinical Investigation of Keratose as an Excipient of Drug Coated Balloons.
    Goel E; Erwin M; Cawthon CV; Schaff C; Fedor N; Rayl T; Wilson O; Christians U; Register TC; Geary RL; Saul J; Yazdani SK
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32244375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of drug-coated balloon for the treatment of multiple peripheral artery segments.
    Anderson JA; Lamichhane S; Fuglsby K; Remund T; Pohlson K; Evans R; Engebretson D; Kelly P
    J Vasc Surg; 2020 May; 71(5):1750-1757.e7. PubMed ID: 31519510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental evaluation of pharmacokinetic profile and biological effect of a novel paclitaxel microcrystalline balloon coating in the iliofemoral territory of swine.
    Buszman PP; Milewski K; Zurakowski A; Pajak J; Jelonek M; Gasior P; Peppas A; Tellez A; Granada JF; Buszman PE
    Catheter Cardiovasc Interv; 2014 Feb; 83(2):325-33. PubMed ID: 23703720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an automated micropipette coating method for drug-coated balloons.
    Fuglsby K; Anderson JA; Engebretson D; Lamichhane S
    J Biomed Mater Res B Appl Biomater; 2020 Jul; 108(5):2258-2275. PubMed ID: 31967398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic Evaluation of Two Paclitaxel-Coated Balloons with Different Drug Load in a Short-Term Porcine Study.
    Abadal JM; Vazquez E; Morales M; Toro A; Quintana M; Araujo M
    Cardiovasc Intervent Radiol; 2016 Aug; 39(8):1152-8. PubMed ID: 27094691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue uptake, distribution, and healing response after delivery of paclitaxel via second-generation iopromide-based balloon coating: a comparison with the first-generation technology in the iliofemoral porcine model.
    Buszman PP; Tellez A; Afari ME; Peppas A; Conditt GB; Rousselle SD; McGregor JC; Stenoien M; Kaluza GL; Granada JF
    JACC Cardiovasc Interv; 2013 Aug; 6(8):883-90. PubMed ID: 23968706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound controlled paclitaxel releasing system-A novel method for improving the availability of coronary artery drug coated balloon.
    Song C; Zhou C; Zhang J; Feng X; Cui X; Zhang F; Ma J; Toft ES; Ge J; Zhang H
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):E119-E128. PubMed ID: 31659805
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Turner E; Erwin M; Atigh M; Christians U; Saul JM; Yazdani SK
    Front Pharmacol; 2018; 9():808. PubMed ID: 30104972
    [No Abstract]   [Full Text] [Related]  

  • 15. Understanding the Mechanism of Drug Transfer and Retention of Drug-Coated Balloons.
    Villar-Matamoros E; Stokes L; Lloret A; Todd M; Tillman BW; Yazdani SK
    J Cardiovasc Pharmacol Ther; 2022; 27():10742484221119559. PubMed ID: 35972237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of balloon coating process for paclitaxel coated balloons via micro-pipetting method.
    Woolford SE; Tran M; NguyenPho A; McDermott MK; Oktem B; Wickramasekara S
    Int J Pharm; 2019 Jan; 554():312-321. PubMed ID: 30395954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrophilic Coating Microstructure Mediates Acute Drug Transfer in Drug-Coated Balloon Therapy.
    Shazly T; Eberth JF; Kostelnik CJ; Uline MJ; Chitalia VC; Spinale FG; Alshareef A; Kolachalama VB
    ACS Appl Bio Mater; 2024 May; 7(5):3041-3049. PubMed ID: 38661721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel-coated versus plain old balloon angioplasty for the treatment of infrainguinal arterial disease in diabetic patients: the Belgian diabetic IN.PACT Trial.
    Debing E; Aerden D; Vanhulle A; Gallala S; von Kemp K;
    J Cardiovasc Surg (Torino); 2017 Aug; 58(4):528-534. PubMed ID: 27727202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic Drug Effect and Particulate Embolization of Drug-Eluting Stents versus Drug-Coated Balloons in Healthy Swine Femoropopliteal Arteries.
    Torii S; Yahagi K; Mori H; Harari E; Romero ME; Kolodgie FD; Young B; Ragheb A; Virmani R; Finn AV
    J Vasc Interv Radiol; 2018 Jul; 29(7):1041-1049.e3. PubMed ID: 29754850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Particulate Embolization after Femoral Artery Treatment with IN.PACT Admiral versus Lutonix 035 Paclitaxel-Coated Balloons in Healthy Swine.
    Kolodgie FD; Pacheco E; Yahagi K; Mori H; Ladich E; Virmani R
    J Vasc Interv Radiol; 2016 Nov; 27(11):1676-1685.e2. PubMed ID: 27641674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.